TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
125 hedge funds and large institutions have $812M invested in Trillium Therapeutics Inc. in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 36 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
27% less capital invested
Capital invested by funds: $1.12B → $812M (-$307M)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
125
Holding in Top 10
4
Calls
$12.5M
Puts
$6.34M
Top Buyers
| 1 | +$30.9M | |
| 2 | +$8.91M | |
| 3 | +$6.22M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.21M |
| 5 |
AG
Artal Group
Luxembourg
|
+$4.3M |
Top Sellers
| 1 | -$22.5M | |
| 2 | -$14.9M | |
| 3 | -$8.81M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$8.53M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.97M |